Physician profile
Kyle Pate
NPI 1427580919
$1,392.11
in general payments reported to CMS, 2019-2025
12 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $88.33 · 2023: $646 · 2024: $525 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $443.12 | 2023-2024 | Ruby Coil, Penumbra System, Smart Coil |
| Balt USA, LLC | $318.60 | 2023-2024 | Prestige Coil System, Ballast 088 Long Sheath |
| Boston Scientific Corporation | $272.62 | 2023-2024 | |
| Inari Medical, INC. | $88.33 | 2022 | |
| Imperative Care, INC | $83.75 | 2024-2025 | Symphony Catheter |
| Siemens Medical Solutions USA, INC. | $68.11 | 2025 | Microthermx Microwave Ablation System |
| Shockwave Medical, INC | $29.72 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $24.80 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Cardiva Medical, INC. | $20.08 | 2024 | Cardiva Vascade 5f Vcs |
| Stryker Corporation | $15.93 | 2023 | Target |
| Argon Medical Devices, INC. | $13.95 | 2025 | Clot Management |
| Terumo Medical Corporation | $13.10 | 2023 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Pate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.